Victory Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.54M | Buy |
|
|||||
|
2025
Q1 | $4.96M | Sell |
|
|||||
|
2024
Q4 | $18.3M | Buy |
|
|||||
|
2024
Q3 | $7.12M | Buy |
|
|||||
|
2024
Q2 | $8.33M | Buy |
|
|||||
|
2024
Q1 | $7.68M | Sell |
|
|||||
|
2023
Q4 | $9.6M | Sell |
|
|||||
|
2023
Q3 | $10.6M | Buy |
|
|||||
|
2023
Q2 | $9.67M | Sell |
|
|||||
|
2023
Q1 | $14.9M | Buy |
|
|||||
|
2022
Q4 | $13.5M | Sell |
|
|||||
|
2022
Q3 | $62.3M | Buy |
|
|||||
|
2022
Q2 | $59M | Sell |
|
|||||
|
2022
Q1 | $58M | Sell |
|
|||||
|
2021
Q4 | $65.1M | Buy |
|
|||||
|
2021
Q3 | $56.9M | Buy |
|
|||||
|
2021
Q2 | $59.8M | Sell |
|
|||||
|
2021
Q1 | $54.2M | Sell |
|
|||||
|
2020
Q4 | $65.4M | Sell |
|
|||||
|
2020
Q3 | $58.6M | Buy |
|
|||||
|
2020
Q2 | $92.2M | Buy |
|
|||||
|
2020
Q1 | $20.8M | Buy |
|
|||||
|
2019
Q4 | $10.2M | Buy |
|
|||||
|
2019
Q3 | $7.84M | Sell |
|
|||||
|
2019
Q2 | $16.4M | Sell |
|
|||||
|
2019
Q1 | $34.1M | Sell |
|
|||||
|
2018
Q4 | $45.7M | Sell |
|
|||||
|
2018
Q3 | $56.9M | Sell |
|
|||||
|
2018
Q2 | $64.5M | Sell |
|
|||||
|
2018
Q1 | $61M | Sell |
|
|||||
|
2017
Q4 | $70.2M | Sell |
|
|||||
|
2017
Q3 | $79.6M | Sell |
|
|||||
|
2017
Q2 | $77.8M | Sell |
|
|||||
|
2017
Q1 | $81.2M | Sell |
|
|||||
|
2016
Q4 | $118M | Buy |
|
|||||
|
2016
Q3 | $117M | Buy |
|
|||||
|
2016
Q2 | $92.2M | Sell |
|
|||||
|
2016
Q1 | $111M | Buy |
|
|||||
|
2015
Q4 | $140M | Buy |
|
|||||
|
2015
Q3 | $140M | Sell |
|
|||||
|
2015
Q2 | $184M | Sell |
|
|||||
|
2015
Q1 | $173M | Sell |
|
|||||
|
2014
Q4 | $130M | Buy |
|